文献速递妇科

长链非编码RNA对卵巢癌化疗反应的影响

The influence of long non-coding RNAs on the response to chemotherapy in ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2019-12-26

本文综述了长链非编码RNA(lncRNA)在卵巢癌对铂类、紫杉烷类及PARP抑制剂等药物反应中的作用。现有数据支持部分lncRNA单独或联合其他分子作为预测治疗反应的潜在生物标志物,理解其作用决定因素可能揭示新的治疗靶点。

要点

  • lncRNA在多数恶性肿瘤中作为癌基因或抑癌基因参与癌症 hallmark 通路。
  • 已有数据支持部分lncRNA作为卵巢癌治疗反应预测的潜在生物标志物。

核心结论

  • 现有数据支持若干lncRNA单独或与其他分子联合作为预测卵巢癌治疗反应的潜在生物标志物。
  • 理解lncRNA作用决定因素可能揭示新的潜在治疗靶点。

研究设计与样本

  • 综述,总结lncRNA在卵巢癌对当前治疗药物反应中作用的研究。

主要发现

  • 越来越多研究将lncRNA与卵巢癌生物学的多个方面联系起来。
  • 综述涵盖lncRNA参与卵巢癌对一线铂类、紫杉烷类及新近可用PARP抑制剂等不同药物反应的研究。

临床怎么用

  • 部分lncRNA有潜力作为预测卵巢癌治疗反应的生物标志物,可单独或联合其他分子使用。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With 240,000 new cases and 152,000 deaths per year, ovarian cancer is the leading cause of death from gynecologic malignancies. Late diagnosis because of asymptomatic development in early stages and resistance to existing treatments are the major causes of therapeutic failure in ovarian cancer. The recent discovery of tens of thousands of long non-coding RNAs and their action as oncogenes or tumor suppressors in pathways matching all the hallmarks of cancer in most - if not all - malignancies have attracted attention of the scientific community. A growing number of studies have implicated lncRNAs in diverse aspects of ovarian carcinoma biology. We present lncRNAs which have been involved in response to the different drugs currently used for the treatment of ovarian cancers, from first-line platinum salts and taxanes to the newly available PARP inhibitors. The data already available supports the potential use of several lncRNAs, alone or in combination with other molecules, as potential biomarkers for the prediction of response to treatment. Understanding the determinants of their action might reveal new potential therapeutic targets.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Wambecke A, Ahmad M, Lambert B, et al. The influence of long non-coding RNAs on the response to chemotherapy in ovarian cancer. Gynecol Oncol. 2019. PMID: 31883617. doi:10.1016/j.ygyno.2019.12.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。